UBS AM
WGS icon

UBS AM’s GeneDx Holdings WGS Stock Holding History

UBS AM’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.73M Sell
54,336
-195,096
-78% -$11.1M ﹤0.01% 1749
2026
Q1 		$16M Sell
249,432
-9,313
-4% -$849K ﹤0.01% 970
2025
Q4 		$33.7M Buy
258,745
+227,088
+717% +$31.2M 0.01% 702
2025
Q3 		$3.41M Sell
31,657
-16,504
-34% -$1.8M ﹤0.01% 1543
2025
Q2 		$4.45M Buy
48,161
+19,937
+71% +$1.57M ﹤0.01% 1769
2025
Q1 		$2.5M Buy
28,224
+11,375
+68% +$987K ﹤0.01% 1884
2024
Q4 		$1.3M Buy
16,849
+9,202
+120% +$643K ﹤0.01% 2251
2024
Q3 		$325K Buy
+7,647
New +$258K ﹤0.01% 2719
2023
Q1 		– Sell
-3,564
Closed -$31K – 2721
2022
Q4 		$31K Hold
3,564
– – ﹤0.01% 2515
2022
Q3 		$103K Sell
3,564
-762
-18% -$34.9K ﹤0.01% 2684
2022
Q2 		$180K Buy
4,326
+1,647
+61% +$112K ﹤0.01% 2595
2022
Q1 		$271K Hold
2,679
– – ﹤0.01% 2619
2021
Q4 		$394K Buy
+2,679
New +$599K ﹤0.01% 2620

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

UBS AM's WGS Position: Q2 2026 in Review

UBS AM reduced its GeneDx Holdings (WGS) stake by 78% in Q2 2026, selling an estimated $11.1M and leaving 54,336 shares worth $3.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1749.

UBS AM first reported a position in WGS in Q4 2021 and has held it in 13 quarters since. The position peaked at $33.7M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • UBS AM held 54,336 shares of GeneDx Holdings worth $3.73M as of Q2 2026.
  • UBS AM sold 195,096 GeneDx Holdings shares in Q2 2026, an estimated $11.1M.
  • GeneDx Holdings made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1749 holding.
  • UBS AM first reported a position in GeneDx Holdings in Q4 2021 and has held it in 13 quarters since.
  • UBS AM's GeneDx Holdings position peaked at $33.7M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.